News

Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
BioSpace1d
Vinay Prasad Overruled Reviewers on Moderna’s COVID-19 Shot for Kids
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
MedPage Today on MSN6d
FDA OKs Moderna's COVID Shot for Kids
Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months through 11 years. Novavax's COVID shot (Nuvaxovid) is fully approved for people ...